Your browser doesn't support javascript.
loading
Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatment.
Russo, D; Malagola, M; Skert, C; Cancelli, V; Turri, D; Pregno, P; Bergamaschi, M; Fogli, M; Testoni, N; De Vivo, A; Castagnetti, F; Pungolino, E; Stagno, F; Breccia, M; Martino, B; Intermesoli, T; Cambrin, G R; Nicolini, G; Abruzzese, E; Tiribelli, M; Bigazzi, C; Usala, E; Russo, S; Russo-Rossi, A; Lunghi, M; Bocchia, M; D'Emilio, A; Santini, V; Girasoli, M; Lorenzo, R Di; Bernardi, S; Palma, A Di; Cesana, B M; Soverini, S; Martinelli, G; Rosti, G; Baccarani, M.
Afiliación
  • Russo D; Unit of Blood Diseases and Stem Cell Transplantation, University of Brescia, Brescia, Italy.
  • Malagola M; Unit of Blood Diseases and Stem Cell Transplantation, University of Brescia, Brescia, Italy.
  • Skert C; Unit of Blood Diseases and Stem Cell Transplantation, University of Brescia, Brescia, Italy.
  • Cancelli V; Unit of Blood Diseases and Stem Cell Transplantation, University of Brescia, Brescia, Italy.
  • Turri D; Ematologia 1-TMO, AOR Villa Sofia-Cervello, Palermo, Italy.
  • Pregno P; S.C. Ematologia, Dipartimento di Oncologia ed Ematologia, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy.
  • Bergamaschi M; Dipartimento di Terapie Oncologiche Integrate, IRCCS AOU S. Martino-IST, Genova, Italy.
  • Fogli M; Institute of Hematology 'L. & A. Seràgnoli', DIMES, University of Bologna, Bologna, Italy.
  • Testoni N; Institute of Hematology 'L. & A. Seràgnoli', DIMES, University of Bologna, Bologna, Italy.
  • De Vivo A; Institute of Hematology 'L. & A. Seràgnoli', DIMES, University of Bologna, Bologna, Italy.
  • Castagnetti F; Institute of Hematology 'L. & A. Seràgnoli', DIMES, University of Bologna, Bologna, Italy.
  • Pungolino E; Division of Hematology, Department of Oncology and Hematology, Niguarda Ca' Granda Hospital, Milan, Italy.
  • Stagno F; Divisione Clinicizzata di Ematologia AOU Policlinico-V. Emanuele, University of Catania, Catania, Italy.
  • Breccia M; Azienda Policlinico Umberto I, Sapienza Università, Roma, Italy.
  • Martino B; Hematology Unit, 'Bianchi-Melacrino-Morelli' Hospital, Reggio Calabria, Italy.
  • Intermesoli T; Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
  • Cambrin GR; University of Turin, San Luigi Gonzaga Hospital, Turin, Italy.
  • Nicolini G; Hematology and Hematopoietic Stem Cell Transplant Center, San Salvatore Hospital, Pesaro, Italy.
  • Abruzzese E; Hematology, S Eugenio Hospital Tor Vergata University, Rome, Italy.
  • Tiribelli M; Division of Hematology and BMT, Azienda Ospedaliero-Universitaria di Udine, Udine, Italy.
  • Bigazzi C; Hematology, Mazzoni Hospital, Ascoli Piceno, Italy.
  • Usala E; U O Ematologia e CTMO Ospedale A., Businco-Cagliari, Italy.
  • Russo S; UOC Ematologia AOU 'G Martino' Policlinico Universitario di Messina, Messina, Italy.
  • Russo-Rossi A; Division of Hematology, University of Bari, Bari, Italy.
  • Lunghi M; Division of Hematology, Department of Clinical and Experimental Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
  • Bocchia M; Hematology and Transplants, University of Siena and AOUS, Siena, Italy.
  • D'Emilio A; Department of Cellular Therapies and Haematology, San Bortolo Hospital, Vicenza, Italy.
  • Santini V; Unità di Ematologia, AOU Careggi, University of Florence, Florence, Italy.
  • Girasoli M; Hematology Department, 'A. Perrino' Hospital, Brindisi, Italy.
  • Lorenzo RD; Division of Haematology, Spirito Santo Hospital, Pescara, Italy.
  • Bernardi S; Unit of Blood Diseases and Stem Cell Transplantation, University of Brescia, Brescia, Italy.
  • Palma AD; Unit of Blood Diseases and Stem Cell Transplantation, University of Brescia, Brescia, Italy.
  • Cesana BM; DMMT, Unit of Medical Statistics, University of Brescia, Brescia, Italy.
  • Soverini S; Institute of Hematology 'L. & A. Seràgnoli', DIMES, University of Bologna, Bologna, Italy.
  • Martinelli G; Institute of Hematology 'L. & A. Seràgnoli', DIMES, University of Bologna, Bologna, Italy.
  • Rosti G; Institute of Hematology 'L. & A. Seràgnoli', DIMES, University of Bologna, Bologna, Italy.
  • Baccarani M; Department of Haematology-Oncology 'L. and A. Seràgnoli' - S. Orsola Malpighi Hospital, University of Bologna, Bologna, Italy.
Blood Cancer J ; 5: e347, 2015 Sep 18.
Article en En | MEDLINE | ID: mdl-26383820

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Mesilato de Imatinib / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Blood Cancer J Año: 2015 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Mesilato de Imatinib / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Blood Cancer J Año: 2015 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos